These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 22545141)

  • 1. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
    Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
    PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.
    Meng X; Neises A; Su RJ; Payne KJ; Ritter L; Gridley DS; Wang J; Sheng M; Lau KH; Baylink DJ; Zhang XB
    Mol Ther; 2012 Feb; 20(2):408-16. PubMed ID: 22108860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
    Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S
    Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.
    Phang RZ; Tay FC; Goh SL; Lau CH; Zhu H; Tan WK; Liang Q; Chen C; Du S; Li Z; Tay JC; Wu C; Zeng J; Fan W; Toh HC; Wang S
    Stem Cells Transl Med; 2013 Dec; 2(12):935-45. PubMed ID: 24167318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
    Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
    Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human induced pluripotent stem cells from cord blood cells.
    Nishishita N; Takenaka C; Fusaki N; Kawamata S
    J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector.
    Sommer CA; Sommer AG; Longmire TA; Christodoulou C; Thomas DD; Gostissa M; Alt FW; Murphy GJ; Kotton DN; Mostoslavsky G
    Stem Cells; 2010 Jan; 28(1):64-74. PubMed ID: 19904830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live cell monitoring of hiPSC generation and differentiation using differential expression of endogenous microRNAs.
    Kamata M; Liang M; Liu S; Nagaoka Y; Chen IS
    PLoS One; 2010 Jul; 5(7):e11834. PubMed ID: 20676373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
    Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
    Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector.
    Papapetrou EP; Sadelain M
    Nat Protoc; 2011 Aug; 6(9):1251-73. PubMed ID: 21886095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
    Febbraro F; Chen M; Denham M
    Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.
    Sommer CA; Christodoulou C; Gianotti-Sommer A; Shen SS; Sailaja BS; Hezroni H; Spira A; Meshorer E; Kotton DN; Mostoslavsky G
    PLoS One; 2012; 7(12):e51711. PubMed ID: 23272148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming Human Fibroblasts to Induced Pluripotent Stem Cells Using the GFP-Marked Lentiviral Vectors in the Chemically Defined Medium.
    Shao Z; Cevallos RR; Hu K
    Methods Mol Biol; 2021; 2239():101-116. PubMed ID: 33226615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A site-specific genetic modification for induction of pluripotency and subsequent isolation of derived lung alveolar epithelial type II cells.
    Yan Q; Quan Y; Sun H; Peng X; Zou Z; Alcorn JL; Wetsel RA; Wang D
    Stem Cells; 2014 Feb; 32(2):402-13. PubMed ID: 24123810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Human Induced Pluripotent Stem Cells from Extraembryonic Tissues of Fetuses Affected by Monogenic Diseases.
    Spitalieri P; Talarico RV; Botta A; Murdocca M; D'Apice MR; Orlandi A; Giardina E; Santoro M; Brancati F; Novelli G; Sangiuolo F
    Cell Reprogram; 2015 Aug; 17(4):275-87. PubMed ID: 26474030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.